Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luh

Showing results (1461-1470 of 1,486) with videos related to

Pageof 149
Sort By:
Cell Chemical Biology|July 18, 2024
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesiaYi-Han Huang, Shu-Yu Lin, Li-Chin Ou, et al.
Blood Cancer Journal|September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology|March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaMin-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutationsSao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
American Journal of Hematology|May 22, 2014
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patientsYi-Tsung Yang, Hsin-An Hou, Chieh-Yu Liu, et al.
Blood Cancer Journal|January 22, 2024
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutationsFeng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
Vaccines|May 25, 2024
Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac<sup>®</sup>) as a Booster Dose against COVID-19 in Indonesian AdultsKusnandi Rusmil, Eddy Fadlyana, Rodman Tarigan Girsang, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Oncotarget|January 27, 2016
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemiaHsin-An Hou, Chieh-Yu Liu, Yuan-Yeh Kuo, et al.
Oncotarget|August 17, 2016
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)Chi-Yuan Yao, Hsin-An Hou, Tzung-Yi Lin, et al.
Pageof 149

Showing results (1461-1470 of 1,486) with videos related to

Sort By:
Pageof 149
Cell Chemical Biology|July 18, 2024
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesiaYi-Han Huang, Shu-Yu Lin, Li-Chin Ou, et al.
Blood Cancer Journal|September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemiaFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology|March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaMin-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutationsSao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
American Journal of Hematology|May 22, 2014
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patientsYi-Tsung Yang, Hsin-An Hou, Chieh-Yu Liu, et al.
Blood Cancer Journal|January 22, 2024
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutationsFeng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
Vaccines|May 25, 2024
Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac<sup>®</sup>) as a Booster Dose against COVID-19 in Indonesian AdultsKusnandi Rusmil, Eddy Fadlyana, Rodman Tarigan Girsang, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Oncotarget|January 27, 2016
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemiaHsin-An Hou, Chieh-Yu Liu, Yuan-Yeh Kuo, et al.
Oncotarget|August 17, 2016
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)Chi-Yuan Yao, Hsin-An Hou, Tzung-Yi Lin, et al.
Pageof 149